Support and Resistance Levels
Past performance
About Metropolis Healthcare Ltd Metropolis Healthcare Ltd, a leading diagnostics company in India, has a strong presence across 220 cities, particularly in West and South India. Established in 1980, it evolved from a pathology business into a comprehensive diagnostic service provider. The company operates through a hub-and-spoke model, ensuring efficient service delivery across its network of 115 laboratories, including a global reference hub in Mumbai, regional, satellite, and express labs, some of which are located internationally. Metropolis is recognized for its quality services, having received awards for excellence in customer service.
The company has expanded through acquisitions, such as the full stake purchase in Dr. Ganesan's Hitech Diagnostics in 2021-22, and launched advanced tests using Next Generation Sequencing technology in 2022-23. Metropolis also provides support services for clinical research organizations. Its shares are listed on BSE and NSE, following a successful IPO in April 2019. The company focuses on growth, technology integration, and expanding its test offerings, making it a key player in India's healthcare diagnostics sector.